New DOJ Memo Warns Employers: Rethink DEI Programs Now - #WorkforceWednesday® - Employment Law This Week®
Strengthening Your Hiring Process
Off the Clock, On the Radar: Managing Off-Duty Conduct and Workplace Impact
Blowing the Whistle: What Employers Should Know About DEI & the False Claims Act
Law Firm ERGs Under Scrutiny: Navigating Compliance, Risk, and Culture - On Record PR
The Changing Landscape of EEOC Enforcement and Disparate Impact
Work This Way: A Labor & Employment Law Podcast | Episode 44: Conducting Effective Workplace Investigations with Kimberly Hewitt and Antwan Lofton of Duke University
Navigating DEI in a Shifting Legal Landscape: Insights From Late Night — Hiring to Firing Podcast
What's the Tea in L&E? Why You Need Policies for Temps and Other Contractors
A Deep Dive into HUD's New Guidance on AI-Driven Targeted Advertising — The Consumer Finance Podcast
Non-Disparagement Settlements in New Jersey, DOL's AI Guidelines, OSHA Regions Shift - Employment Law This Week®
What's the Tea in L&E? Weight Discrimination
The Burr Broadcast: EEOC Strategic Enforcement Plan
Work This Way: A Labor & Employment Law Podcast | Episode 3: Top Labor & Employment Issues for 2024 with Jennie Cluverius, Cherie Blackburn, and Christy Rogers
Updates to Statute 1557 that Healthcare Providers Need to Know
DE Under 3: New Administrative Review Board Decision from March Sets Down New Backpay Calculation in Litigated OFCCP Cases
DE Under 3: OFCCP Discrimination Enforcement Statistics Hit New Lows
#WorkforceWednesday: NLRB Issues Stericycle Decision, EEOC Proposes Pregnant Worker Rule, EEOC Settles First AI Anti-Discrimination Suit - Employment Law This Week®
DE Under 3: OFCCP Announced “Pre-Enforcement Notice & Conciliation Procedures” Final Rule
What's the Tea in L&E? Tattoos, Piercings, and Leggings, Oh My! Is It Time To Review Your Workplace Dress Code?
California legislators recently introduced AB 1460, which would prohibit prescription drug manufacturers from engaging in discriminatory practices aimed at providers participating in the 340B drug pricing program (covered...more
Despite political and economic uncertainties, markets and deal activity were resilient in 2019, and strong fundamentals remain in place heading into 2020. Companies continue to face a challenging litigation and enforcement...more